• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liver tissue microbiome in NAFLD: next step in understanding the gut-liver axis?

作者信息

Tilg Herbert, Burcelin Remy, Tremaroli Valentina

机构信息

Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria

Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 1048, Toulouse, France.

出版信息

Gut. 2020 Aug;69(8):1373-1374. doi: 10.1136/gutjnl-2019-320490. Epub 2020 Feb 14.

DOI:10.1136/gutjnl-2019-320490
PMID:32060128
Abstract
摘要

相似文献

1
Liver tissue microbiome in NAFLD: next step in understanding the gut-liver axis?非酒精性脂肪性肝病中的肝脏组织微生物群：理解肠-肝轴的下一步？
Gut. 2020 Aug;69(8):1373-1374. doi: 10.1136/gutjnl-2019-320490. Epub 2020 Feb 14.
2
The role of the microbiome in NAFLD and NASH.微生物组在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的作用。
EMBO Mol Med. 2019 Feb;11(2). doi: 10.15252/emmm.201809302.
3
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.综述文章：肠道微生物组在非酒精性脂肪性肝病进展中的新作用及其潜在的治疗意义。
Aliment Pharmacol Ther. 2019 Jul;50(2):144-158. doi: 10.1111/apt.15314. Epub 2019 May 31.
4
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.
5
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.肠-肝轴、营养与非酒精性脂肪性肝病。
Clin Biochem. 2015 Sep;48(13-14):923-30. doi: 10.1016/j.clinbiochem.2015.06.023. Epub 2015 Jul 4.
6
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群：非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
7
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.台湾经活检证实的非酒精性脂肪性肝病患者的肠道微生物失调：一项横断面研究。
Nutrients. 2020 Mar 19;12(3):820. doi: 10.3390/nu12030820.
8
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.微生物群与非酒精性脂肪性肝病：有氧运动能力和生活方式改变的潜在影响
Physiol Genomics. 2017 Aug 1;49(8):385-399. doi: 10.1152/physiolgenomics.00012.2017. Epub 2017 Jun 9.
9
Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).用营养干预、益生菌、合生菌和粪便微生物群移植（FMT）来对抗脂肪肝疾病。
Adv Exp Med Biol. 2019;1125:85-100. doi: 10.1007/5584_2018_318.
10
Gut microbiota and non-alcoholic fatty liver disease.肠道微生物群与非酒精性脂肪性肝病
Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):572-81. doi: 10.1016/s1499-3872(15)60026-1.

引用本文的文献

1
Lactiplantibacillus plantarum attenuate gossypol-induced hepatic lipotoxicity by altering intestinal microbiota for enriching microbial tryptophan metabolites in Nile tilapia (Oreochromis niloticus).植物乳杆菌通过改变尼罗罗非鱼（Oreochromis niloticus）的肠道微生物群以富集微生物色氨酸代谢物来减轻棉酚诱导的肝脏脂毒性。
Microbiome. 2025 Aug 4;13(1):180. doi: 10.1186/s40168-025-02172-0.
2
The carotenoid torularhodin alleviates NAFLD by promoting Akkermanisa muniniphila-mediated adenosylcobalamin metabolism.类胡萝卜素球红酵母红素通过促进嗜黏蛋白阿克曼氏菌介导的腺苷钴胺素代谢来缓解非酒精性脂肪性肝病。
Nat Commun. 2025 Apr 8;16(1):3338. doi: 10.1038/s41467-025-58500-3.
3
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.
肝细胞癌发生过程中病因依赖的微生物组差异
Int J Mol Sci. 2024 Dec 17;25(24):13510. doi: 10.3390/ijms252413510.
4
Effect of Bile Acids Supplementation in Fatty Liver Hemorrhagic Syndrome, Production Performance, Physiological and Quality Characteristics of Laying Hen Eggs.补充胆汁酸对蛋鸡脂肪肝出血综合征、生产性能、生理及蛋品质特性的影响
Animals (Basel). 2024 Jun 28;14(13):1910. doi: 10.3390/ani14131910.
5
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities.肠道微生物群在导致体重紊乱及相关合并症中的作用。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0004523. doi: 10.1128/cmr.00045-23. Epub 2024 Jun 28.
6
Regulation Mechanism and Potential Value of Active Substances in Spices in Alcohol-Liver-Intestine Axis Health.香料活性物质在酒精性肝肠轴健康中的调控机制及潜在价值。
Int J Mol Sci. 2024 Mar 27;25(7):3728. doi: 10.3390/ijms25073728.
7
The Reduced Gut Species Is Linked to Liver Enzyme Elevation and Insulin Resistance in Pediatric Fatty Liver Disease.肠道菌群减少与儿童非酒精性脂肪性肝病肝酶升高和胰岛素抵抗相关。
Int J Mol Sci. 2024 Mar 25;25(7):3640. doi: 10.3390/ijms25073640.
8
Electroacupuncture treatment ameliorates metabolic disorders in obese ZDF rats by regulating liver energy metabolism and gut microbiota.电针治疗通过调节肝脏能量代谢和肠道微生物群改善肥胖 ZDF 大鼠的代谢紊乱。
Front Endocrinol (Lausanne). 2023 Jun 27;14:1207574. doi: 10.3389/fendo.2023.1207574. eCollection 2023.
9
Whole-body microbiota of newborn calves and their response to prenatal vitamin and mineral supplementation.新生犊牛的全身微生物群及其对产前维生素和矿物质补充的反应。
Front Microbiol. 2023 Jun 26;14:1207601. doi: 10.3389/fmicb.2023.1207601. eCollection 2023.
10
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders.肠道微生物群与主要非肿瘤性肝胆胰疾病的抗生素治疗
Antibiotics (Basel). 2023 Jun 17;12(6):1068. doi: 10.3390/antibiotics12061068.